Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar

Journal of Infection and Chemotherapy

Volumn 22, Issue 3, 2016, Pages 174-179

  Aye, Khin Saw ^a   Nakajima, Chie ^b   Yamaguchi, Tomoyuki ^b   Win, Min Min ^a   Shwe, Mu Mu ^a   Win, Aye Aye ^a   Lwin, Thandar ^c   Nyunt, Wint Wint ^c   Ti, Ti ^c   Suzuki, Yasuhiko ^b  

^a Department of Medical Research ^*  (Myanmar)

^b HOKKAIDO UNIVERSITY   (Japan)

^c National TB Program   (Myanmar)

Author keywords

Isoniazid; Myanmar; Mycobacterium tuberculosis; Resistance; Rifampicin

Indexed keywords

BACTERIAL PROTEIN; INHA PROTEIN; ISONIAZID; KATG PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG; DNA DIRECTED RNA POLYMERASE; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CODON; DNA SEQUENCE; GENOTYPE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION RATE; MYANMAR; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROMOTER REGION; REGULATORY SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYANMAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84960225605     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2015.12.009     Document Type: Article

References (32)

1. World Health Organization Global tuberculosis report 2014, http://www.who.int/tb/publications/global_report/gtbr14_main_text.pdf?ua=1.
2. Nathanson E., Nunn P., Uplekar M., Floyd K., Jaramillo E., Lönnroth K., et al. MDR tuberculosis-critical steps for prevention and control. N Engl J Med 2010, 363:1050-1058.
3. Phyu S., Ti T., Jureen R., Hmun T., Myint H., Htun A., et al. Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar. Emerg Infect Dis 2003, 9:274-276.
4. Phyu S., Lwin T., Ti T., Maung W., Mar W.W., Shein S.S., et al. Drug-resistant tuberculosis in Yangon, Myanmar. Scand J Infect Dis 2005, 37:846-851.
5. Aung W.W., Ti T., Than K.K., Thida M., Nyein M.M., Htun Y.Y., et al. Study of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar. Southeast Asian J Trop Med Public Health 2007, 38:104-110.
6. Ti T. National anti-tuberculosis drug resistance survey, 2002, in Myanmar. Int J Tuberc Lung Dis 2006, 10:1111-1116.
7. Zhang Y., Yew W.W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:1320-1330.
8. Agdamag D.M.D., Kageyama S., Solante R., Espantaleon A.S., Sangco J.C., Suzuki Y. Characterization of clinical isolates of Mycobacterium tuberculosis resistant to drugs and detection of rpoB mutation in multidrug-resistant tuberculosis in the Philippines. Int J Tuberc Lung Dis 2003, 2003:1104-1108.
9. Kourout M., Chaoui I., Sabouni R., Lahlou O., El Mzibri M., Jordaan A., et al. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Morocco. Int J Tuberc Lung Dis 2009, 13:1440-1442.
10. Paluch-Oles J., Kozioł-Montewka M., Magrys A. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates from Eastern Poland. New Microbiol 2009, 32:147-152.
11. Prammananan T., Cheunoy W., Taechamahapun D., Yorsangsukkamol J., Phunpruch S., Phdarat P., et al. Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for mutation detection. Clin Microbiol Infect 2008, 14:446-453.
12. Suresh N., Singh U.B., Arora J., Pant H., Seth P., Sola C., et al. rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India. Infect Genet Evol 2006, 6:474-483.
13. Valim A.R., Rossetti M.L., Ribeiro M.O., Zaha A. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil. J Clin Microbiol 2000, 38:3119-3122.
14. Guo J.H., Xiang W.-L., Zhao Q.-R., Luo T., Huang M., Zhang J., et al. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Sichuan Province in China. Jpn J Infect Dis 2008, 61:264-268.
15. Minh N.N., Van Bac N., Son N.T., Lien V.T., Ha C.H., Cuong N.H., et al. Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam. J Clin Microbiol 2012, 50:598-601.
16. Poudel A., Nakajima C., Fukushima Y., Suzuki H., Pandey B.D., Maharjan B., et al. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal. Antimicrob Agents Chemother 2012, 56:2831-2836.
17. Rahim Z., Nakajima C., Raqib R., Zaman K., Endtz H.P., van der Zanden A.G., et al. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh. Tuberculosis 2012, 92:529-534.
18. Siddiqi N., Shamim M., Hussain S., Choudhary R.K., Ahmed N., Prachee, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002, 46:443-450.
19. Torres M.J., Criado A., Gónzalez N., Palomares J.C., Aznar J. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis 2002, 6:160-163.
20. Valvatne H., Syre H., Kross M., Stavrum R., Ti T., Phyu S., et al. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. J Antimicrob Chemother 2009, 64:694-701.
21. Yoon J.H., Nam J.S., Kim K.J., Choi Y., Lee H., Cho S.N., et al. Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea. Diagn Microbiol Infect Dis 2012, 72:52-61.
22. Boonaiam S., Chaiprasert A., Prammananan T., Leechawengwongs M. Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand. Clin Microbiol Infect 2010, 16:396-399.
23. Mathuria J.P., Nath G., Samaria J.K., Anupurba S. Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India. Infect Genet Evol 2009, 9:1352-1355.
24. Nusrath Unissa A., Selvakumar N., Narayanan S., Narayanan P.R. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Int J Antimicrob Agents 2008, 31:71-75.
25. Hall A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41:95-98.
26. Aung W.W., Ei P.W., Nyunt W.W., Swe T.L., Lwin T., Htwe M.M., et al. Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar. Ann Lab Med 2015, 35:494-499. 10.3343/alm.2015.35.5.494.
27. Heep M., Brandstätter B., Rieger U., Lehn N., Richter E., Rüsch-Gerdes S., et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001, 39:107-110.
28. Hirano K., Abe C., Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 1999, 37:2663-2666.
29. Hui J., Gordon N., Kajioka R. Permeability barrier to rifampin in mycobacteria. Antimicrob Agents Chemother 1977, 11:773-779.
30. Rouse D.A., DeVito J.A., Li Z., Byer H., Morris S.L. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol 1996, 22:583-592.
31. Afanas'ev M.V., Ikryannikova L.N., Il'ina E.N., Sidorenko S.V., Kuz'min A.V., Larionova E.E., et al. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother 2007, 59:1057-1064. PMID: 17442757.
32. Borgdorff M.W., van Soolingen D. The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?. Clin Microbiol Rev 2013, 26:342-360. 10.1128/CMR.00087-12.